GRABAR LAW OFFICE INVESTIGATES POTENTIAL SHAREHOLDER ACTION ON BEHALF OF CURRENT SHAREHOLDERS OF ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (NASDAQ: MDRX)
Current Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) shareholders who have held shares of the Company’s stock since at least January 2018, have standing to seek corporate reforms, the return of funds back to company coffers and potentially a court approved incentive award if appropriate.
Allscripts has agreed to pay a $145 million to settle Department of Justice (DOJ) allegations related to cloud-based electronic health record company Practice Fusion, which Allscripts acquired in 2018. In settling, the company admitted that it “solicited and received kickbacks from a major opioid company” in exchange for clinical decision support (CDS) alerts promoting unnecessary prescription opioids, according to a release from the DOJ. The DOJ investigation found that Practice Fusion Inc. accepted payments that constitute kickbacks in violation of the federal Anti-Kickback Statute and Civil Monetary Penalties Law, and related state statutes.
Unlike a class action, brought on behalf of investors, a shareholder derivative action is an action brought by a shareholder of a public company on behalf of and for the benefit of the company itself against the directors and/or officers of that company. In a derivative action, shareholders “step into the shoes” of the directors and officers of a company and bring litigation that the board would be unwilling to pursue on its own.
If you would like to learn more at no cost to you, fill out the form provided or contact us at email@example.com or call 267-507-6085.